Highlights:
- Gaudium IVF IPO has been subscribed 1.32 times with bids for 1.92 crore shares.
- Grey market premium stands at 11% over the ₹79 upper price band.
- The issue closes on 24 February 2026, with UPI mandate confirmation deadline set at 5:00 PM.
The initial public offering of GAUDIUMIVF has garnered steady investor participation as the issue enters its final bidding phase. The IPO, which opened on 20 February 2026 and closes on 24 February 2026, is priced in the range of ₹75 to ₹79 per equity share. As per available subscription data, the issue has been subscribed 1.32 times, while grey market activity indicates shares trading at a premium over the upper price band.
Subscription Details and Grey Market Trend
The IPO comprises a fresh issue of 1,13,92,500 equity shares along with an offer for sale of 94,93,700 equity shares, including an anchor investor portion of 62,65,860 equity shares. The total issue size stands at 1,46,20,340 equity shares under the 100% book-building route.
The offering received bids for 1,92,93,498 shares against the total issue size, translating to an overall subscription of 1.32 times. At the cut-off price, bids were recorded for 1,19,12,103 shares.
As per media reports, shares are trading at an 11% premium in the grey market over the upper band of ₹79. Market observers are closely tracking this trend as the bidding window approaches closure.
Price Band, Lot Size and Investor Limits
The price range for the IPO is fixed at ₹75 to ₹79 per equity share with a face value of ₹5. The minimum bid lot is 189 equity shares and in multiples thereafter. Retail investors can apply up to a maximum subscription amount of ₹2,00,000.
For Qualified Institutional Buyers (QIBs), the maximum bid quantity stands at 1,46,20,284 equity shares, while Non-Institutional Buyers (NIBs) can bid for up to 1,04,43,006 equity shares, calculated at the higher price band.
IPO market timings are from 10:00 a.m. to 5:00 p.m. The cut-off time for UPI mandate confirmation is 24 February 2026 up to 5:00 PM. Applications with confirmed mandate amount blocked status (RC100) will be considered valid.
Financial Performance
Gaudium IVF and Women Health Ltd, incorporated in 2015, operates fertility centres across multiple Indian cities.
For the financial year ended 31 March 2025, the company reported total income of ₹7,095.84 lakh compared to ₹4,815.31 lakh in the previous year. Profit before tax stood at ₹2,542.25 lakh for FY25 against ₹1,663.16 lakh in FY24.
Net profit for FY25 was ₹1,912.74 lakh, compared to ₹1,031.69 lakh in the previous year. Basic and diluted earnings per share for FY25 were ₹3.12, compared to ₹1.68 in FY24.
Total expenses for FY25 were ₹4,553.59 lakh, compared to ₹3,152.15 lakh in the preceding financial year.
With subscription crossing 1.32 times and grey market activity indicating an 11% premium, the Gaudium IVF IPO has generated measured interest from investors. As the bidding window closes on 24 February 2026, focus remains on final subscription figures and allotment outcomes.
FAQs
- What is the price band for the Gaudium IVF IPO?
The IPO is priced between ₹75 and ₹79 per equity share.
- What is the minimum lot size for retail investors?
The minimum bid lot is 189 equity shares and bids must be placed in multiples of 189 shares.
- When is the last date and UPI mandate deadline?
The IPO closes on 24 February 2026, and the UPI mandate confirmation deadline is 5:00 PM on the same day.